Abstract
Background
Sevoflurane is commonly used in general anesthesia for premature neonates. The main mechanism of retinopathy of prematurity (ROP) is increased levels of vascular endothelial growth factor (VEGF). For the investigation of sevoflurane’s effect on angiogenesis, the angiogenesis and VEGF expression in the retina were measured after administering sevoflurane in an oxygen-induced retinopathy mice model.
Materials and methods
The mice were divided into the normoxic group (Nc and Ns group; n = 6) and the ROP group (C, Rc, and Rs group; n = 6). Rc group were exposed to 75% oxygen for 5 days beginning on postnatal day (P) 7, and then returned to room air. Age-matched mice in the C group were exposed to room air. To observe angiogenesis of the retina, the mice were sacrificed on P16. The Rs group was exposed to 2 vol% sevoflurane for 2 h on P12, P13, and P14 with 40% oxygen.
Results
The angiogenic area and the spreading distance of vessels on P4 were statistically decreased in the Ns group, compared to the Nc group. The avascular area on P16 was significantly increased and the expression of VEGF was suppressed in the Rs group compared to the Rc group.
Conclusions
Sevoflurane can inhibit retinal angiogenesis via suppressing VEGF expression in an OIR mice model with exposure to relative hypoxia. Nevertheless, it is still difficult to apply the results of this study immediately to humans because of the heterogeneity of responses to sevoflurane.
Similar content being viewed by others
References
Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, Requejo JH, Rubens C, Menon R, Van Look PF. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ. 2010;88(1):31–8.
Austeng D, Källen KB, Ewald UW, Jakobsson PG, Holmström GE. Incidence of retinopathy of prematurity in infants born before 27 weeks’ gestation in Sweden. Arch Ophthalmol. 2009;127(10):1315–9.
Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis. 2007;10(2):133–40.
Stahl A, Connor KM, Sapieha P, Chen J, Dennison RJ, Krah NM, Seaward MR, Willett KL, Aderman CM, Guerin KI, Hua J, Löfqvist C, Hellström A, Smith LE. The mouse retina as an angiogenesis model. Investig Ophthalmol Vis Sci. 2010;51(6):2813–26.
Anand D, Etuwewe B, Clark D, Yoxall C. Anaesthesia for treatment of retinopathy of prematurity. Arch Dis Child Fetal Neonatal Ed. 2007;92(2):F154–5.
Chen J, Stahl A, Hellstrom A, Smith LE. Current update on retinopathy of prematurity: screening and treatment. Curr Opin Pediatr. 2011;23(2):173.
Hartrey R. Anaesthesia for the laser treatment of neonates with retinopathy of prematurity. Eye. 2007;21(8):1025–7.
Neema C. Anesthetic concerns in patients with retinopathy of prematurity. J Case Rep. 2013;3(1):59–63.
Hassid S, Nicaise C, Michel F, Vialet R, Thomachot L, Lagier P, Martin C. Randomized controlled trial of sevoflurane for intubation in neonates. Pediatr Anesth. 2007;17(11):1053–8.
Yu L, Sun H, Yao L, Feng Y, Yang B. Comparison of effective inspired concentration of sevoflurane in preterm infants with different postconceptual ages. Pediatr Anesth. 2011;21(2):148–52.
Hellström A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet. 2013;382(9902):1445–57.
Lu Y, Wang J, Yan J, Yang Y, Sun Y, Huang Y, Hu R, Zhang Y, Jiang H. Sevoflurane attenuate hypoxia-induced VEGF level in tongue squamous cell carcinoma cell by upregulating the DNA methylation states of the promoter region. Biomed Pharmacother. 2015;71:139–45.
Shi Q, Zhang S, Liu L, Chen Q, Yu L, Zhang F, Zhang F, Yan M. Sevoflurane promotes the expansion of glioma stem cells through activation of hypoxia-inducible factors in vitro. Br J Anaesth. 2014;2014:aeu402.
Smith L, Wesolowski E, McLellan A, Kostyk SK, D’Amato R, Sullivan R, D’Amore PA. Oxygen-induced retinopathy in the mouse. Investig Ophthalmol Vis Sci. 1994;35(1):101–11.
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 2001;25(4):402–8.
Istaphanous GK, Howard J, Nan X, Hughes EA, McCann JC, McAuliffe JJ, Danzer SC, Loepke AW. Comparison of the neuroapoptotic properties of equipotent anesthetic concentrations of desflurane, isoflurane, or sevoflurane in neonatal mice. J Am Soc Anesthesiol. 2011;114(3):578–87.
Liu C, Shen Z, Liu Y, Peng J, Miao L, Zeng W, Li Y. Sevoflurane protects against intestinal ischemia–reperfusion injury partly by phosphatidylinositol 3 kinases/Akt pathway in rats. Surgery. 2015;157(5):924–33.
Zhang Y, Tian S-Y, Li Y-W, Zhang L, Yu J-B, Li J, Chen YY, Wang YX, Liang Y, Zhang XS, Wang WS, Liu HG. Sevoflurane preconditioning improving cerebral focal ischemia–reperfusion damage in a rat model via PI3K/Akt signaling pathway. Gene. 2015;569(1):60–5.
Lai Z, Zhang L, Su J, Cai D, Xu Q. Sevoflurane postconditioning improves long-term learning and memory of neonatal hypoxia-ischemia brain damage rats via the PI3K/Akt-mPTP pathway. Brain Res. 2016;1630:25–37.
Dimmeler S, Zeiher AM. Akt takes center stage in angiogenesis signaling. Circ Res. 2000;86(1):4–5.
Zhang L, Zhang J, Dong Y, Swain CA, Zhang Y, Xie Z. The potential dual effects of sevoflurane on AKT/GSK3β signaling pathway. Med Gas Res. 2014;4(1):1.
Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med. 2005;9(2):267–85.
Barnett JM, McCollum GW, Fowler JA, Duan JJ-W, Kay JD, Liu R-Q, Bingaman DP, Penn JS. Pharmacologic and genetic manipulation of MMP-2 and-9 affects retinal neovascularization in rodent models of OIR. Investig Ophthalmol Vis Sci. 2007;48(2):907–15.
Liang H, Gu M, Yang C, Wang H, Wen X, Zhou Q. Sevoflurane inhibits invasion and migration of lung cancer cells by inactivating the p38 MAPK signaling pathway. J Anesth. 2012;26(3):381–92.
Wilder RT, Flick RP, Sprung J, Katusic SK, Barbaresi WJ, Mickelson C, Gleich SJ, Schroeder DR, Weaver AL, Warner DO. Early exposure to anesthesia and learning disabilities in a population-based birth cohort. J Am Soc Anesthesiol. 2009;110(4):796–804.
Flick RP, Katusic SK, Colligan RC, Wilder RT, Voigt RG, Olson MD, Sprung J, Weaver AL, Schroeder DR, Warner DO. Cognitive and behavioral outcomes after early exposure to anesthesia and surgery. Pediatrics. 2011;2011:peds. 2011-0351.
Acknowledgements
The authors thank the Department of Pharmacology, Gene and Cell Therapy Center for Vessel-associated Disease, Medical Research Institute, Pusan National University School of Medicine, Yangsan, Republic of Korea for the excellent technical assistance.
Author information
Authors and Affiliations
Contributions
HYK, S-HB, SSB, JMH, and MK: study design and data analysis. HYK, S-HB, SWB, SSB, JMH, G-JB, HJK, H-SR, and SHK: manuscript preparation.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have competing interests.
About this article
Cite this article
Kim, H.Y., Baek, SH., Baik, S.W. et al. The effect of sevoflurane on retinal angiogenesis in a mouse model of oxygen-induced retinopathy. J Anesth 32, 204–210 (2018). https://doi.org/10.1007/s00540-018-2465-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-018-2465-0